Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.43 USD | -2.01% | -2.13% | +9.38% |
Evolution of the average Target Price on AnaptysBio, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AnaptysBio, Inc.
Leerink Partners | |
Wells Fargo Securities | |
JPMorgan Chase | |
Wedbush | |
BTIG | |
Piper Sandler | |
UBS | |
Guggenheim | |
Raymond James | |
HC Wainwright | |
Truist Securities | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- ANAB Stock
- Consensus AnaptysBio, Inc.